The concept for OrthoPediatrics originated in the mid 1980's as a business idea to provide better splinting and bracing for orthopaedic problems in children, however, because of the highly competitive nature and low margins, the business never materialised.
The last decade has seen regulatory reform in the US enabling paediatric orthopaedic products a high priority path through the FDA, including the declaration of Juvenile Arthritis as a National Healthcare Priority in 2000, the Medical Devices Technical Corrections Act in 2004, and the Pediatric Medical Device Safety and Improvement Act in 2007; all of which have helped remove some of the barriers to increase the availability of devices for the treatment of conditions affecting children, thus allowing OrthoPediatrics the opportunity to effectively and exclusively focus on this area.
OrthoPediatrics was formally established in 2006 by Nick Deeter, when he put together a business team of orthopaedic experts in engineering, marketing, regulatory, finance and manufacturing from Warsaw, Indiana, the "Orthopedic Capital of the World". In order to ensure the clinical success of the devices, he also requested the help of many elite paediatric orthopaedic surgeons from across the USA. Together, the business team and surgeon experts are inventing and designing a superior orthopaedic implant range for children.
Up the 2010, the OrthoPediatrics product range was only available in the USA. In 2011, following the granting of CE certification, several OrthoPediatrics products are now available in the UK, Ireland and other countries in Europe. Click here for further details.